SEARCH RESULTS FOR: "Tag: ALLO"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(1)
2019(2)
CATEGORIES
Analyst Update(2)
Buzz Stocks(1)

5/14/2020 9:34 AM
Allogene Therapeutics Inc (NASDAQ:ALLO) this morning released well-received data from its phase-one study of its non-Hodgkin lymphoma treatment, ALLO-501. The oncology firm expects to initiate the ne...
11/4/2019 9:16 AM
CAR-T therapy has been the big thing in oncology in recent years, and one name at the forefront of the immuno-oncology movement is Allogene Therapeutics Inc (NASDAQ:ALLO). In fact, Canaccord Genuity ...
5/3/2019 2:08 PM
Ahead of earnings next Tuesday, May 7, Oppenheimer initiated coverage of Allogene Therapeutics Inc (NASDAQ:ALLO) with an "outperform" rating. In addition, the brokerage firm set a lofty price targe...
PEOPLE ALSO SEARCH FOR